Ophthalmology · Patchogue, NY
NPI
1588628911
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
14a Jayne Avenue
Patchogue, NY, 11772
Phone (631) 475-0222
Groups this clinician bills Medicare through
Medicare paid, 2024
$605K
6,616 services
Medicare patients, 2024
548
Average age 75
Drug cost, 2024
$1.2M
3,658 prescriptions
Company payments, 2025
$1,959
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle Guevarra Pena was code J2781 (injection, pegcetacoplan, intravitreal, 1 mg), 945 times for 13 patients. In total Michelle Guevarra Pena billed 6,616 services in 45 codes, and Medicare paid $605K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 945 | 13 | $116.48 | $110K |
| 92012 Ophthalmological E&M | Office | 724 | 402 | $67.78 | $49K |
| 92083 Vision, Hearing, and Speech Services | Office | 635 | 424 | $55.14 | $35K |
| 99212 Office E&M - Established | Office | 581 | 352 | $53.77 | $31K |
| 92133 Computerized Ophthalmic Imaging | Office | 520 | 398 | $30.55 | $16K |
| 83861 Clinical Chemistry | Office | 473 | 201 | $22.03 | $10K |
| 99213 Office E&M - Established | Office | 418 | 295 | $82.71 | $35K |
| 83516 Immunoassay | Office | 368 | 159 | $11.30 | $4,158 |
| 92250 Angiography | Office | 325 | 279 | $30.88 | $10K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 238 | 162 | $216.62 | $52K |
| 67028 Intravitreal Injection | Office | 163 | 33 | $102.46 | $17K |
| 92014 Ophthalmological E&M | Office | 146 | 117 | $96.28 | $14K |
| J0178 Injection, aflibercept, 1 mg | Office | 90 | 12 | $657.84 | $59K |
| 92134 Computerized Ophthalmic Imaging | Office | 82 | 66 | $32.77 | $2,687 |
| 92020 Ophthalmological E&M | Office | 79 | 72 | $23.59 | $1,864 |
By year: 2022 $473K for 5,232 services; 2023 $502K for 5,735 services; 2024 $605K for 6,616 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 473 | 201 | $22.03 | $10K |
| 83516 Immunoassay | 368 | 159 | $11.30 | $4,158 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Guevarra Pena prescribed most often to Medicare patients was Latanoprost, with 967 prescriptions and refills. In total Michelle Guevarra Pena wrote 3,658 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 967 | 2,263 | 279 | $13K |
| Lumigan Bimatoprost | 375 | 825 | 106 | $246K |
| Ketorolac Tromethamine Generic | 359 | 453 | 260 | $10K |
| Restasis Cyclosporine | 350 | 869 | 185 | $528K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 304 | 677 | 90 | $6,979 |
| Brimonidine Tartrate Generic | 166 | 378 | 50 | $25K |
| Dorzolamide Hcl Generic | 156 | 348 | 52 | $3,687 |
| Timolol Maleate Generic | 113 | 260 | 28 | $14K |
| Prednisolone Acetate Generic | 109 | 168 | 67 | $6,798 |
| Cyclosporine Generic | 101 | 284 | 51 | $74K |
| Ofloxacin Generic | 71 | 83 | 53 | $1,195 |
| Xdemvy Lotilaner | 60 | 83 | 52 | $108K |
| Erythromycin Erythromycin Base | 52 | 52 | 42 | $552 |
| Bromfenac Sodium Generic | 48 | 64 | Under 11 | $11K |
| Xiidra Lifitegrast | 35 | 75 | Under 11 | $50K |
Brand drugs: 1,531 claims; generic drugs: 2,127 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle Guevarra Pena $1,959 ($1,959 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $583.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $583 |
| Glaukos Corporation GKOS | 2 | $423 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $281 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $183 |
| Alcon Vision LLC ALC | 5 | $109 |
| Harrow Eye, LLC | 4 | $94.91 |
| Dompe US, Inc. | 2 | $83.5 |
| Biotissue Holdings Inc. | 3 | $73.63 |
| Amgen Inc. AMGN | 2 | $49.92 |
| Sandoz Inc. SDZ.SW | 1 | $24.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.